- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Dual receptor Tyrosine Kinase Inhibitor
Total 82239 results
-
AVEO Pharmaceuticals, Inc.CompletedCarcinoma, Renal CellUkraine, India, Russian Federation
-
Daiichi Sankyo, Inc.CompletedAcute Myeloid Leukemia | Leukemia | AML | Myelodysplastic Syndrome | MDSUnited States, Georgia
-
Seagen Inc.Array BioPharmaCompleted
-
National Taiwan University HospitalCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Adenocarcinoma of the Lung | Large Cell Lung CancerUnited States
-
Janssen Research & Development, LLCCompletedCarcinoma, HepatocellularChina, Taiwan, Korea, Republic of
-
Institut de Recherches Internationales ServierCompletedSolid TumorsItaly, France, Spain
-
National Cancer Institute (NCI)TerminatedAdenocarcinoma | Carcinoma, Squamous Cell | Carcinoma, Non-Small Cell Lung | Carcinoma, Large CellUnited States
-
Novartis PharmaceuticalsNo longer availableFLT3-mutated Acute Myeloid LeukemiaCanada
-
Northwestern UniversityAVEO Pharmaceuticals, Inc.CompletedRecurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue SarcomaUnited States
-
GlaxoSmithKlineCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedRecurrent IDHwt Gliomas With FGFR3-TACC3 Fusion | Recurrent IDHwt Gliomas With FGFR1-TACC1 FusionFrance
-
Northwestern UniversityGenentech, Inc.; Amgen; OSI PharmaceuticalsCompleted
-
Hoffmann-La RocheTerminatedAdvanced or Metastatic Solid TumorsUnited States
-
Tesaro, Inc.CompletedSolid Tumors | LymphomasUnited Kingdom, United States, Taiwan, Spain, Poland
-
Astellas Pharma Global Development, Inc.Terminated
-
Sierra Oncology, Inc.TerminatedEGFR Mutated EGFR TKI Naive Metastatic NSCLCUnited States
-
Haihua YangUnknown
-
Clifford Hospital, Guangzhou, ChinaUnknownCarcinoma, Non-Small-Cell LungChina
-
Astellas Pharma IncTerminatedEGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating MutationsJapan
-
H. Lee Moffitt Cancer Center and Research InstitutePfizer; National Comprehensive Cancer NetworkCompleted
-
SOLTI Breast Cancer Research GroupNovartisCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)Withdrawn
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedAdult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Recurrent Adult Brain Tumor | Tumors Metastatic to Brain | Adult Anaplastic OligoastrocytomaUnited States
-
Children's Oncology GroupCompletedRefractory or Recurrent Solid Tumors, Excluding CNS TumorsUnited States, Canada
-
AIO-Studien-gGmbHAstraZenecaTerminatedNSCLC | Non-squamous Non-small Cell Lung Cancer Stage II | Non-squamous Non-small Cell Lung Cancer Stage IIIA | Non-squamous Non-small Cell Lung Cancer Stage IIIB | Activating EGFR MutationGermany
-
Masonic Cancer Center, University of MinnesotaTerminated
-
Manmeet Ahluwalia, MDNational Cancer Institute (NCI); NovartisCompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)WithdrawnGastrinoma | Glucagonoma | Insulinoma | Pancreatic Polypeptide Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma
-
M.D. Anderson Cancer CenterOSI PharmaceuticalsTerminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Bayer; Genzyme, a Sanofi Company; Amgen; Georgia...CompletedLeukemia | Acute Myelogenous LeukemiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbCompletedNon-Small-Cell Lung CarcinomaUnited States
-
GlaxoSmithKlineCompleted
-
Zaiwen FanUnknownAdvanced Cancer | Lung Cancer, Nonsmall Cell
-
Sun Yat-sen UniversityHangzhou ACEA Pharmaceutical Research Co., Ltd.; Acea Bio (Hangzhou) Co., Ltd.UnknownNon-Small Cell Lung CancerChina
-
Heather WakeleeNovartis; Genentech, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC), Recurrent | Non-small Cell Lung Cancer (NSCLC), Stage IVUnited States
-
NYU Langone HealthNovartisTerminatedProstatic Neoplasms | Prostate CancerUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Myeloid Leukemia/Other Myeloid MalignanciesUnited States
-
Hangzhou Cancer HospitalUnknownNon-small Cell Lung Cancer | Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)China
-
M.D. Anderson Cancer CenterUnited States Department of Defense; AstraZenecaTerminated
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Bulgaria, Spain, Poland, Finland, United Kingdom, Austria, Italy, Greece, Czech Republic, Croatia
-
Memorial Sloan Kettering Cancer CenterCompletedLung Cancer | Non-small Cell Lung Cancer | Bronchioloalveolar CancerUnited States
-
Tianjin Medical University Cancer Institute and...UnknownCarcinoma, Non-Small Cell LungChina
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR Mutated NSCLC.Taiwan
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); NovartisWithdrawnUnspecified Adult Solid Tumor, Protocol Specific | Duct Cell Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic CancerUnited States
-
Vanderbilt-Ingram Cancer CenterTerminatedRecurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal CancerUnited States
-
AGO Study GroupPhilipps University Marburg Medical Center; HSK Reasearch GmbH WiesbadenCompletedPlatinum Refractory Epithelial Ovarian Cancer | Primary Cancer of the Peritoneum | Cancer of the Fallopian TubeGermany
-
Chinese Society of Lung CancerCompletedNon-Small Cell Lung CancerChina
-
Astex Pharmaceuticals, Inc.TerminatedLymphoma | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
China Medical University HospitalTerminated